{"id":"https://openalex.org/W90353023","doi":null,"title":"Calcipotriol in the treatment of childhood vitiligo.","display_name":"Calcipotriol in the treatment of childhood vitiligo.","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W90353023","mag":"90353023","pmid":"https://pubmed.ncbi.nlm.nih.gov/15575172"},"language":"en","primary_location":{"id":"pmid:15575172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15575172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066502872","display_name":"Ali Mohamed Gargoom","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A M Gargoom","raw_affiliation_strings":["Dermatology Department, Jamahiriya Hospital, Benghazi, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department, Jamahiriya Hospital, Benghazi, Libya","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056205020","display_name":"Gamal Ahmed Duweb","orcid":"https://orcid.org/0009-0005-5703-5700","observed_orcids":["https://orcid.org/0009-0005-5703-5700"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G A Duweb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072768450","display_name":"A H Elzorghany","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A H Elzorghany","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060939078","display_name":"M Benghazil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Benghazil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021975676","display_name":"Omran O. Bugrein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O O Bugrein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2687,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.48163563,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"24","issue":"1","first_page":"11","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12355","display_name":"Genetic and rare skin diseases.","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcipotriol","display_name":"calcipotriol","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pediatric-vitiligo","display_name":"pediatric vitiligo","score":0.9739999771118164},{"id":"https://openalex.org/keywords/topical-calcipotriol","display_name":"topical calcipotriol","score":0.7369999885559082},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5450000166893005},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9179999828338623},{"id":"https://openalex.org/keywords/segmental-vitiligo","display_name":"segmental vitiligo","score":0.9559999704360962},{"id":"https://openalex.org/keywords/focal-vitiligo","display_name":"focal vitiligo","score":0.7390000224113464},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.4020000100135803},{"id":"https://openalex.org/keywords/vitamin-d-analogs","display_name":"vitamin D analogs","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9589563012123108},{"id":"https://openalex.org/C2776009542","wikidata":"https://www.wikidata.org/wiki/Q155683","display_name":"Calcipotriol","level":3,"score":0.935928225517273},{"id":"https://openalex.org/C2779980618","wikidata":"https://www.wikidata.org/wiki/Q180152","display_name":"Vitiligo","level":2,"score":0.8881566524505615},{"id":"https://openalex.org/C2777063393","wikidata":"https://www.wikidata.org/wiki/Q77776","display_name":"Irritation","level":2,"score":0.7272692918777466},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6871711611747742},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6810727119445801},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4141691029071808},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21780702471733093},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.1990068256855011},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.07177069783210754},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009824","descriptor_name":"Ointments","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014820","descriptor_name":"Vitiligo","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15575172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15575172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology research","raw_type":"Clinical Trial"},{"id":"mag:90353023","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15575172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2039590722","https://openalex.org/W2081088124","https://openalex.org/W2279472137","https://openalex.org/W1983458913","https://openalex.org/W130542356","https://openalex.org/W176018810","https://openalex.org/W2023252025","https://openalex.org/W2160232170","https://openalex.org/W2142117588","https://openalex.org/W2085999310"],"abstract_inverted_index":{"Eighteen":[0],"patients":[1,40,50,72,86,110,130,149,157,169],"with":[2,196,199],"a":[3],"clinical":[4],"diagnosis":[5],"of":[6,30,36],"vitiligo,":[7,54],"aged":[8],"between":[9],"three":[10,122,156,168],"and":[11,28,44,60,87,103,121,147,167,211],"12":[12,45],"years":[13],"(mean":[14],"8.9":[15],"years),":[16],"were":[17,42,46,112],"enrolled":[18],"in":[19,22,33,70,84,90,127,190,205,207],"this":[20],"study":[21,116],"order":[23],"to":[24,119,124,173],"evaluate":[25],"the":[26,34,91,115,133,140],"efficacy":[27],"tolerability":[29],"topical":[31],"calcipotriol":[32,185],"treatment":[35,75,134,189],"childhood":[37],"vitiligo.":[38,65,191],"Six":[39],"(33.3%)":[41],"males":[43],"females":[47],"(66.7%).":[48],"Fourteen":[49,129],"(77.8%)":[51,144],"had":[52,57,63,151],"focal":[53],"two":[55,61],"(11.1%)":[56,62],"mucosal":[58],"vitiligo":[59],"segmental":[64],"The":[66,74],"face":[67],"was":[68,76,96],"involved":[69],"11":[71],"(61.1%).":[73],"applied":[77],"twice":[78],"daily":[79],"as":[80,88],"50":[81],"microg/gm":[82],"cream":[83],"nine":[85],"ointment":[89,197],"remaining":[92],"patients.":[93],"Treatment":[94],"assessment":[95],"carried":[97],"out":[98],"clinically":[99],"at":[100],"2":[101],"weeks,":[102],"then":[104],"monthly":[105],"for":[106],"4-6":[107],"months.":[108],"Four":[109],"(28.6%)":[111,163],"excluded":[113],"from":[114],"(one":[117],"due":[118,123],"irritation":[120],"lost":[125],"contact":[126],"follow-up).":[128],"(71.4%)":[131],"completed":[132],"course":[135],"(>":[136],"3":[137],"months).":[138],"Of":[139],"treated":[141],"patients,":[142],"ten":[143],"showed":[145,159,164,171],"improvement":[146,166],"four":[148,162],"(22.2%)":[150],"no":[152],"response.":[153],"Among":[154],"responders,":[155],"(21.4%)":[158,170],"complete":[160],"resolution,":[161],"50%-80%":[165],"30%":[172],"<":[174],"50%":[175],"improvement.":[176],"Only":[177],"one":[178],"patient":[179],"(5.5%)":[180],"developed":[181],"irritation.":[182],"In":[183],"conclusion,":[184],"is":[186],"an":[187],"effective":[188],"Better":[192],"results":[193],"are":[194,213],"obtained":[195],"than":[198],"cream.":[200],"Calcipotriol":[201],"can":[202],"be":[203],"helpful":[204],"children":[206],"whom":[208],"potent":[209],"steroids":[210],"PUVA":[212],"not":[214],"advisable.":[215]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}